Submit Deal

ALINAMIN PHARMACEUTICAL

HQ - Tokyo

Summary

Alinamin Pharmaceutical is a pharmaceutical company that engages in the research, development, manufacturing, sales, and marketing of over-the-counter products, quasi-drugs, and other healthcare-related offerings.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 1.66 B

Avg. Deal Size£ 1.66 B

Market Context

Senior Management

Atsushi Morisawa
CEO

Sort

03 Jul 2024|Japan|Pharmaceuticals

Target: ALINAMIN PHARMACEUTICAL

Bidder: MBK PARTNERS

6 Service Providers

2 Target | 1 Bidder | 3 Vendor

20 Dealmakers

2 Target | 1 Bidder | 17 Vendor

£ 1.66 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy